AZN

U.S. FDA Approves Bydureon® Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes

[Business Wire] – AstraZeneca today announced that the U.S. Food and Drug Administration has approved the Bydureon® Pen 2 mg as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click […]

Is Bristol-Myers Squibb All Set for a Strong 2014?

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

3 Hazardous Reasons To Steer Clear Of AstraZeneca plc

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

How does Vodafone’s mega deal affect me?

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

How I will invest my Vodafone windfall money

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

‘How I will invest my Vodafone windfall money’

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

FDA Clears AstraZeneca’s Myalept

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

Where To Reinvest Your Vodafone Group plc Windfall

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

US FDA approves orphan drug MYALEPTâ„¢ (metreleptin for injection)

[at noodls] – AstraZeneca today announced the US Food and Drug Administration (FDA) approved orphan drug MYALEPTâ„¢ (metreleptin for injection), which is indicated as an adjunct to diet as replacement therapy for the … moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]